title: Transplant tolerance: bench to bedside--26th annual Samuel Jason Mixter Lecture.
authors.affiliation: Transplantation Biology Research Center, Massachusetts General Hospital/Harvard Medical School, Boston, MA 02129, USA. david.sachs@tbrc.mgh.harvard.edu
authors.forename: David H
authors.initials: DH
authors.lastname: Sachs
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D016465:Bone Marrow Purging; D017637:Clonal Deletion / Q000276:immunology; D003131:Combined Modality Therapy; D018849:Controlled Clinical Trials as Topic; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006086:Graft vs Host Disease / Q000276:immunology; D007155:Immunologic Factors / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology; D008252:Macaca fascicularis; D051379:Mice; D011828:Radiation Chimera / Q000276:immunology; D000069283:Rituximab; D055502:Secondary Prevention; D013601:T-Lymphocytes / Q000276:immunology; D018183:Transplantation Chimera / Q000276:immunology; D014181:Transplantation Immunology / Q000276:immunology*; D023001:Transplantation Tolerance; D014184:Transplantation, Homologous
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D000069283:Rituximab